252 related articles for article (PubMed ID: 31188831)
21. Interferon Alpha Induces Multiple Cellular Proteins That Coordinately Suppress Hepadnaviral Covalently Closed Circular DNA Transcription.
Cheng J; Zhao Q; Zhou Y; Tang L; Sheraz M; Chang J; Guo JT
J Virol; 2020 Aug; 94(17):. PubMed ID: 32581092
[TBL] [Abstract][Full Text] [Related]
22. IFN-α2b inhibits the ethanol enriched-HBV cccDNA through blocking a positive feedback loop of HBx/MSL2/cccDNA/HBV/HBx in liver.
Liu Z; Wang J; Yuan H; Liu L; Bu Y; Zhao M; Yang G; Feng J; Liu Y; Li J; He Q; Zhang X
Biochem Biophys Res Commun; 2020 Jun; 527(1):76-82. PubMed ID: 32446394
[TBL] [Abstract][Full Text] [Related]
23. Curcumin inhibits hepatitis B virus infection by down-regulating cccDNA-bound histone acetylation.
Wei ZQ; Zhang YH; Ke CZ; Chen HX; Ren P; He YL; Hu P; Ma DQ; Luo J; Meng ZJ
World J Gastroenterol; 2017 Sep; 23(34):6252-6260. PubMed ID: 28974891
[TBL] [Abstract][Full Text] [Related]
24. Establishment of a Rapid Detection System for ISG20-Dependent SARS-CoV-2 Subreplicon RNA Degradation Induced by Interferon-α.
Furutani Y; Toguchi M; Higuchi S; Yanaka K; Gailhouste L; Qin XY; Masaki T; Ochi S; Matsuura T
Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34769072
[TBL] [Abstract][Full Text] [Related]
25. Lack of a role of the interferon-stimulated response element-like region in interferon alpha -induced suppression of Hepatitis B virus in vitro.
Rang A; Heise T; Will H
J Biol Chem; 2001 Feb; 276(5):3531-5. PubMed ID: 11106638
[TBL] [Abstract][Full Text] [Related]
26. Interferon-induced degradation of the persistent hepatitis B virus cccDNA form depends on ISG20.
Stadler D; Kächele M; Jones AN; Hess J; Urban C; Schneider J; Xia Y; Oswald A; Nebioglu F; Bester R; Lasitschka F; Ringelhan M; Ko C; Chou WM; Geerlof A; van de Klundert MA; Wettengel JM; Schirmacher P; Heikenwälder M; Schreiner S; Bartenschlager R; Pichlmair A; Sattler M; Unger K; Protzer U
EMBO Rep; 2021 Jun; 22(6):e49568. PubMed ID: 33969602
[TBL] [Abstract][Full Text] [Related]
27. Persistent Loss of Hepatitis B Virus Markers in Serum without Cellular Immunity by Combination of Peginterferon and Entecavir Therapy in Humanized Mice.
Uchida T; Imamura M; Hayes CN; Hiraga N; Kan H; Tsuge M; Abe-Chayama H; Zhang Y; Makokha GN; Aikata H; Miki D; Ochi H; Ishida Y; Tateno C; Chayama K
Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28696237
[TBL] [Abstract][Full Text] [Related]
28. Interferon-Induced Macrophage-Derived Exosomes Mediate Antiviral Activity Against Hepatitis B Virus Through miR-574-5p.
Wu W; Wu D; Yan W; Wang Y; You J; Wan X; Xi D; Luo X; Han M; Ning Q
J Infect Dis; 2021 Feb; 223(4):686-698. PubMed ID: 32663850
[TBL] [Abstract][Full Text] [Related]
29. Formation of covalently closed circular DNA in Hep38.7-Tet cells, a tetracycline inducible hepatitis B virus expression cell line.
Ogura N; Watashi K; Noguchi T; Wakita T
Biochem Biophys Res Commun; 2014 Sep; 452(3):315-21. PubMed ID: 25150444
[TBL] [Abstract][Full Text] [Related]
30. Betaine Inhibits Hepatitis B Virus with an Advantage of Decreasing Resistance to Lamivudine and Interferon α.
Zhang M; Wu X; Lai F; Zhang X; Wu H; Min T
J Agric Food Chem; 2016 May; 64(20):4068-77. PubMed ID: 27144395
[TBL] [Abstract][Full Text] [Related]
31. Novel type I interferon IL-28A suppresses hepatitis C viral RNA replication.
Zhu H; Butera M; Nelson DR; Liu C
Virol J; 2005 Sep; 2():80. PubMed ID: 16146571
[TBL] [Abstract][Full Text] [Related]
32. Antiviral activity of various interferons and pro-inflammatory cytokines in non-transformed cultured hepatocytes infected with hepatitis B virus.
Isorce N; Testoni B; Locatelli M; Fresquet J; Rivoire M; Luangsay S; Zoulim F; Durantel D
Antiviral Res; 2016 Jun; 130():36-45. PubMed ID: 26971407
[TBL] [Abstract][Full Text] [Related]
33. PASylated interferon α efficiently suppresses hepatitis B virus and induces anti-HBs seroconversion in HBV-transgenic mice.
Xia Y; Schlapschy M; Morath V; Roeder N; Vogt EI; Stadler D; Cheng X; Dittmer U; Sutter K; Heikenwalder M; Skerra A; Protzer U
Antiviral Res; 2019 Jan; 161():134-143. PubMed ID: 30439382
[TBL] [Abstract][Full Text] [Related]
34. Reduction of covalently closed circular DNA with long-term nucleos(t)ide analogue treatment in chronic hepatitis B.
Lai CL; Wong D; Ip P; Kopaniszen M; Seto WK; Fung J; Huang FY; Lee B; Cullaro G; Chong CK; Wu R; Cheng C; Yuen J; Ngai V; Yuen MF
J Hepatol; 2017 Feb; 66(2):275-281. PubMed ID: 27639844
[TBL] [Abstract][Full Text] [Related]
35. Efficacy of NVR 3-778, Alone and In Combination With Pegylated Interferon, vs Entecavir In uPA/SCID Mice With Humanized Livers and HBV Infection.
Klumpp K; Shimada T; Allweiss L; Volz T; Lütgehetmann M; Hartman G; Flores OA; Lam AM; Dandri M
Gastroenterology; 2018 Feb; 154(3):652-662.e8. PubMed ID: 29079518
[TBL] [Abstract][Full Text] [Related]
36. Suppression of USP18 Potentiates the Anti-HBV Activity of Interferon Alpha in HepG2.2.15 Cells via JAK/STAT Signaling.
Li L; Lei QS; Zhang SJ; Kong LN; Qin B
PLoS One; 2016; 11(5):e0156496. PubMed ID: 27227879
[TBL] [Abstract][Full Text] [Related]
37. Insights on the antiviral mechanisms of action of the TLR1/2 agonist Pam3CSK4 in hepatitis B virus (HBV)-infected hepatocytes.
Desmares M; Delphin M; Chardès B; Pons C; Riedinger J; Michelet M; Rivoire M; Verrier B; Salvetti A; Lucifora J; Durantel D
Antiviral Res; 2022 Oct; 206():105386. PubMed ID: 35963549
[TBL] [Abstract][Full Text] [Related]
38. Analysis of hepatitis B virus populations in an interferon-alpha-treated patient reveals predominant mutations in the C-gene and changing e-antigenicity.
Günther S; Paulij W; Meisel H; Will H
Virology; 1998 Apr; 244(1):146-60. PubMed ID: 9581787
[TBL] [Abstract][Full Text] [Related]
39. Combination therapy of siRNAs mediates greater suppression on hepatitis B virus cccDNA in HepG2.2.15 cell.
Xin XM; Li GQ; Guan XR; Li D; Xu WZ; Jin YY; Gu HX
Hepatogastroenterology; 2008; 55(88):2178-83. PubMed ID: 19260501
[TBL] [Abstract][Full Text] [Related]
40. Targeting hepatitis B virus cccDNA by CRISPR/Cas9 nuclease efficiently inhibits viral replication.
Dong C; Qu L; Wang H; Wei L; Dong Y; Xiong S
Antiviral Res; 2015 Jun; 118():110-7. PubMed ID: 25843425
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
